Recital 6, Decision_act (EU) 2020/1037

In forcesince 15 Jul 2020

Consequently, for reasons beyond the control of the applicant, the approval of acrolein for use in biocidal products of product-type 12 is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of approval of acrolein for use in biocidal products of product-type 12 for a period of time sufficient to enable the examination of the application. Considering the time-limits for the evaluation by the evaluating competent authority and for the preparation and submission of the opinion by the Agency, it is appropriate to postpone the expiry date of approval to 28 February 2023.